Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.76 - $6.86 $432,776 - $789,586
-115,100 Reduced 90.35%
12,300 $51,000
Q2 2024

Aug 14, 2024

BUY
$5.23 - $10.44 $504,695 - $1.01 Million
96,500 Added 312.3%
127,400 $695,000
Q1 2024

May 15, 2024

BUY
$4.2 - $11.27 $126,000 - $338,100
30,000 Added 3333.33%
30,900 $309,000
Q4 2023

Feb 14, 2024

SELL
$2.8 - $4.55 $20,160 - $32,760
-7,200 Reduced 88.89%
900 $3,000
Q3 2023

Nov 14, 2023

BUY
$3.77 - $6.23 $26,013 - $42,987
6,900 Added 575.0%
8,100 $31,000
Q2 2023

Aug 14, 2023

SELL
$3.22 - $7.53 $27,692 - $64,758
-8,600 Reduced 87.76%
1,200 $7,000
Q1 2023

May 15, 2023

BUY
$3.11 - $4.92 $12,440 - $19,680
4,000 Added 68.97%
9,800 $32,000
Q4 2022

Feb 14, 2023

SELL
$3.19 - $6.46 $13,398 - $27,132
-4,200 Reduced 42.0%
5,800 $22,000
Q3 2022

Nov 14, 2022

BUY
$5.58 - $9.04 $55,800 - $90,399
10,000 New
10,000 $60,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $460M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.